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Abstract
Introduction:  End-of-life  (EoL)  care  is  a  major  component  in  the  management  of  patients  with
advanced  COPD.  Patient-physician  communication  is  essential  in  this  process.
Aim: To  evaluate  the  practice  of  Portuguese  Pulmonologists  in  EoL  communication  and  palliative
care in  COPD.
Methods:  An  on-line  survey  was  sent  to  physicians  afﬁliated  to  the  Portuguese  Pneumology
Society.
Results:  We  obtained  136  answers  from  464  eligible  participants  (29.3%).  About  half  of  the
physicians reported  that  they  have  rarely  introduced  EoL  discussions  with  their  COPD  patients
(48.5%). Most  had  never/rarely  suggested  decision-making  on  the  use  of  invasive  mechani-
cal ventilation  (68.4%).  Discussions  were  described  as  occurring  mostly  during/after  a  major
exacerbation  (53.7%).  Only  37.5%  of  participants  reported  treating  dyspnoea  with  opioids  fre-
quently/always.  Only  9.6%  stated  that  they  never/rarely  treated  anxiety/depression.  Most
participants  perceive  the  discussion  of  EoL  issues  as  being  difﬁcult/very  difﬁcult  (89.0%).  The
reasons most  frequently  given  were  feeling  that  patients  were  not  prepared  for  this  discussion
(70.0%),  fear  of  taking  away  a  patient’s  hope  (58.0%)  and  lack  of  training  (51.0%).
Conclusion:  Patient  and  medical  staff  EoL  communication  in  COPD  is  still  not  good  enough.
Training  in  this  area  and  the  creation  of  formal  protocols  to  initiate  EoL  have  been  identiﬁed
as major  factors  for  improvement.
©  2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
PALAVRAS-CHAVE Assistência  a  doentes  terminais  com  DPOC:  um  inquérito  realizado  a  Pneumologistas
DPOC; Portugueses
Cuidados  paliativos;
Fim  de  vida;
Comunicac¸ão
Resumo
Introduc¸ão:  Os  cuidados  terminais  (EoL)  são  um  componente  importante  do  tratamento  de
doentes com  doenc¸a  pulmonar  obstrutiva  crónica  (DPOC)  avanc¸ada.  A  comunicac¸ão  entre  o
doente e  o  médico  é  fundamental  neste  processo.
 This study was performed at: Servic¸o de Pneumologia do Centro Hospitalar Lisboa Norte, EPE - Hospital Pulido Valente, Lisbon, Portugal.
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E-mail address: carina.gaspar@gmail.com (C. Gaspar).
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Objetivo:  Avaliar  a  prática  dos  pneumologistas  portugueses  na  comunicac¸ão  sobre  o  ﬁm  de  vida
e os  cuidados  paliativos  na  DPOC.
Métodos:  Foi  enviado  um  inquérito  online  para  os  médicos  sócios  da  Sociedade  Portuguesa  de
Pneumologia.
Resultados:  Recebemos  136  respostas  dos  464  participantes  elegíveis  (29,3%).  Cerca  de  metade
dos médicos  indicaram  que  raramente  iniciaram  conversas  sobre  o  ﬁm  de  vida  com  os  seus
doentes com  DPOC  (48,5%).  A  maioria  nunca/raramente  sugeriram  a  toma  de  decisão  sobre
a utilizac¸ão  de  ventilac¸ão  mecânica  invasiva  (68,4%).  As  conversas  foram  descritas  como
ocorrendo,  na  sua  maioria,  durante/após  uma  exacerbac¸ão  grave  (53,7%).  Apenas  37,5%  dos
participantes  indicaram  tratar  a  dispneia  frequentemente/sempre  com  opiáceos.  Apenas  9,6%
indicaram que  nunca/raramente  trataram  a  ansiedade/depressão.  A  maioria  dos  participantes
considerou  a  conversa  sobre  questões  de  ﬁm  de  vida  como  sendo  difícil/muito  difícil  (89,0%).
Os motivos  mais  frequentemente  indicados  foram  a  sensac¸ão  de  que  os  doentes  não  estavam
preparados  para  essa  conversa  (70,0%),  medo  de  tirar  a  esperanc¸a aos  doentes  (58,0%)  e  falta
de formac¸ão  (51,0%).
Conclusão:  A  comunicac¸ão  sobre  o  ﬁm  de  vida  entre  o  doente  e  os  médicos  na  DPOC  ainda  não
é suﬁcientemente  boa.  A  formac¸ão  nesta  área  e  a  criac¸ão  de  protocolos  formais  para  iniciar  os
cuidados  em  ﬁm  de  vida  foram  identiﬁcados  como  fatores  importantes  a  melhorar.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
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ntroduction
hronic  obstructive  pulmonary  disease  (COPD)  is  a  chronic
nd  progressive  disease  that  in  its  advanced  stages  may  be
ssociated  with  important  physical,  psychological  and  social
mpairments.  Palliative  care  should  be  provided  to  advanced
OPD  patients  so  as  to  reduce  the  high  burden  of  chronically
ebilitating  symptoms  such  as  dyspnoea  and  anxiety.
Patient--physician  communication  on  prognosis,  prefer-
nces  for  life-sustaining  treatments  and  palliative  care,  is
ssential  to  ensure  that  COPD  patients  receive  end-of-life
EoL)  quality  care  that  is  consistent  with  the  values  upheld.
he  uncertain  disease  trajectory,  which  frequently  involves
nexpected  deterioration  in  health  status,  makes  planning
f  care  in  advance  essential.1
In  recent  years,  there  has  been  a  growing  interest  in
oL  care  in  advanced  COPD.  Some  important  scientiﬁc  soci-
ties  have  published  recommendations  on  this  theme  and
he  Global  Initiative  for  Obstructive  Pulmonary  Disease
GOLD)  introduced  it  for  the  ﬁrst  time  into  the  2013  updated
evision.2--4 The  challenge  remains  in  how  EoL  care  is  imple-
ented  in  practice.  At  present,  there  is  evidence  that  COPD
atients  receive  poor  EoL  care  and  that  there  is  insufﬁcient
atient-physician  discussion  on  EoL  preferences.5,6
We  developed  a  survey  to  characterize  the  Portuguese
ulmonologists’  practice  in  EoL  communication  and  pallia-
ive  care  in  advanced  COPD  patients,  and  identify  hurdles
o  its  consistent  implementation.  With  this  study,  we  hope
o  help  establish  strategies  to  overcome  the  difﬁculties  that
hysicians  face  in  their  every-day  practice,  which  ultimately
ay  lead  to  an  improvement  on  the  EoL  care  that  COPD
atients  receive.
ethodsarticipant  recruitment
n  January  2013  we  asked  the  Portuguese  Pneumology  Soci-
ty  (SPP)  to  provide  us  with  the  mailing  list  of  all  afﬁliated
i
t
w
mespiratory  Medicine  specialists  and  fellows  with  email
ontact.  We  obtained  a list  of  464  members.  We  only  asked
hysicians  who  had  had  clinical  activity  in  the  previous  year
o  answer  the  survey.
uestionnaire  development  and  administration
 self-administrated  questionnaire  was  developed  speciﬁ-
ally  for  this  study.  The  authors  generated  questions  based
n  a  review  of  the  literature.  Questions  were  drawn  up
o  address  four  main  themes:  (1)  palliation  of  symptoms;
2)  frequency  and  topics  of  EoL  communication;  (3)  timing
nd  interveners  of  EoL  communication;  (4)  obstacles  to  EoL
ommunication.
The  following  data  were  collected  to  characterize  par-
icipants:  age,  gender,  religious  beliefs,  years  of  practice,
ype  of  institution,  region  of  the  country  and  number  of
atients  with  COPD  treated  per  year.
At  the  beginning  of  the  questionnaire,  participants  were
sked  to  answer  questions  with  reference  to  the  patients
hey  had  treated  in  the  previous  year,  who  had  two  or  more
f  the  following  characteristics:  forced  expiratory  volume  in
rst  second  (FEV1)  under  30%,  oxygen  dependence,  one  or
ore  hospital  admissions  in  the  previous  year  for  an  acute
xacerbation  of  COPD,  left  heart  failure  or  other  comorbidi-
ies,  weight  loss  or  caquexia,  decreased  functional  status,
ncreasing  dependence  on  others  and  were  over  70  years
ld.  We  adopted  these  criterion  from  Curtis,  whose  purpose
as  to  identify  patients  in  whom  a  discussion  on  preferences
bout  EoL  care  should  be  initiated.5
We  pretested  the  questionnaire  on  a  convenience  sample
f  6  pulmonologists  to  ensure  clarity  and  comprehensive-
ess.  A  web  platform  was  then  designed  to  facilitate  survey
ompletion  and  data  collection.  Participants  received  an
nvitation  to  answer  the  questionnaire  via  an  e-mail  sent  by
he  SPP,  containing  a  link  to  the  online  platform.  One  month
as  allowed  for  questionnaire  completion.  During  the  one
onth  period  two  e-mails  of  reminder  were  sent  to  each
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Table  1  Participant  characteristics.
Age  46.0  (±12.1)
Gender:  female  83  (61.0%)
Religious  beliefs
Believers  83  (61.0%)
Non-believers  34  (25.0%)
‘‘I prefer  not  to  answer’’ 19  (14.0%)
Years of  practice
<5 18  (13.2%)
5--9 27  (19.9%)
10--19 6  (19.1%)
20--29 44  (32.4%)
≥30 21  (15.4%)
Type of  institution
University  hospital  54  (39.7%)
Other  hospital  71  (52.2%)
Primary  health-care  unit  2  (1.5%)
Private  medical
clinic/ofﬁce
9  (6.6%)
Region  of  the  country
North  39  (28.7%)
Centre  17  (12.5%)
Lisboa  and  Vale  do  Tejo  67  (49.3%)
Alentejo  5  (3.7%)
Algarve  6  (4.4%)
Madeira  and  Ac¸ores  2  (1.5%)
Number  of  COPD  patients  treated  in  the  last  year
<50 33  (24.3%)
50--200  71  (52.2%)
>200 32  (23.5%)
Number  of  COPD  patients  treated  in  the  last  year
with 2  or  more  of  the  Curtis′ criteria
<30 74  (54.4%)
30--100  47  (36.4%)
>100 15  (9.2%)
Number  of  EoL  articles  read  in  the  last  6  months
None  53  (39.0%)
1--2 56  (41.2%)
3--9 18  (13.2%)
≥10 9  (6.6%)
Number  of  post-graduate  courses  on  EoL  attended
None  69  (50.7%)
1--2 49  (36.0%)
3--4 12  (8.8%)
≥5 6  (4.4%)
Data are presented as n (%) or mean (±standard deviation);
s
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applicant,  after  which  time  the  website  was  closed.  All  com-
plete  questionnaires  were  considered  eligible  so  that  we  are
characterizing  the  reality  of  our  practice.
Statistical  analysis
Demographic  data  and  the  several  variables  related  to  pal-
liation  and  communication  were  analyzed  using  descriptive
statistics.  To  verify  a  possible  inﬂuence  of  the  participant
characteristics  on  their  ability  to  undertake  EoL  communica-
tion,  a  univariate  analysis  was  performed  between  the  main
characteristics  -- years  of  practice,  type  of  institution  (uni-
versity  hospital  vs  other),  number  of  COPD  patients  treated
--  and  two  questions  evaluated  by  a  semi-quantitative  scale:
(a)  ‘‘How  often  have  you  started  a  EoL  discussion  on  your
initiative?’’;  (b)  ‘‘How  difﬁcult  is  it  for  you  to  discuss  EoL
issues  with  your  patients?’’.  Statistical  signiﬁcance  values
were  set  at  p  ≤  0.05.
Results
From  the  464  eligible  participants,  136  completed  the  ques-
tionnaire  (participation  rate  of  29.3%).  Characteristics  of
respondents  are  summarized  in  Table  1.  Most  respondents
(52.2%)  had  treated  50--200  COPD  patients  in  the  previous
year.
We  questioned  physicians  about  the  number  of  patients
that  would  not  cause  them  surprise  if  they  died  in  the  follow-
ing  year.  Seventy-one  (52.1%)  would  not  be  surprised  if  up  to
30%  of  their  patients  died  in  the  following  year,  56  (41.1%)
admitted  that  30--69%  could  die  in  that  period,  and  only  9
(6.8%)  considered  this  possibility  in  70%  or  more  patients.
Concerning  palliation,  we  asked  physicians  how  often
they  treated  pain,  dyspnoea  (namely  with  opioids)  and
depression/anxiety.  Results  are  summarized  in  Table  2.
The  use  of  opioids  to  manage  dyspnoea  was  reported  to
occur  occasionally  in  32.4%  of  cases  and  frequently/always
in  37.5%.  Respondents  indicated  they  treated  anxiety  and
depression  frequently/always  in  43.4%  of  cases.
The  frequency  of  EoL  communication  and  the  topics  are
presented  in  Table  3.  Most  physicians  (61.7%)  said  they  had
rarely  or  never  initiated  this  type  of  discussion.  The  progres-
sion  of  disease  was  the  topic  most  discussed  by  physicians
with  patients,  but  life  expectancy  and  the  suffering  related
to  death  were  less  often  approached.  Most  respondents  also
claimed  to  have  never  or  rarely  asked  about  patients’  spiri-
tual  or  religious  beliefs  (81.6%).
Regarding  EoL  decision-making,  the  majority  of  par-
ticipants  said  they  never/rarely  suggested  their  patients
to  make  decisions  about  invasive  mechanical  ventila-
tion/intubation  (68.4%),  cardio-pulmonary  resuscitation
(80.8%)  or  whether  they  preferred  to  die  at  home  versus  in
hospital  (75.9%).  Most  had  never  suggested  the  drawing  up
a  written  advance  directive  (80.1%),  although  almost  all  of
them  (95.6%)  were  aware  that  the  Portuguese  law  provides
for  this  possibility.  Only  11.8%  reported  to  have  frequently
referred  COPD  patients  to  hospice  care  services.We  also  inquired  of  participants  what  moment  was  usu-
ally  chosen  for  EoL  discussion.  Discussion  was  reported  to
occur  during  a  major  exacerbation  in  29.4%,  in  advanced  dis-
ease  when  the  patient  is  stable  in  25.0%,  after  the  patient
i
c
(EoL = end-of-life; COPD = chronic obstructive pulmonary disease.
urvives  a  major  exacerbation  in  24.3%,  only  if  patient  or
aregiver  introduces  the  subject  in  14.0%  and  early  after
iagnosis  in  7.4%.
Interveners  usually  included  in  EoL  discussion  are  listed
n  Table  4. Among  healthcare  professionals,  other  physi-
ians  were  the  main  interveners,  followed  by  nurses.  Most
91.0%)  respondents  indicated  that  they  never  or  rarely
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Table  2  Palliation  of  symptoms.
Never  Rarely  Occasionally  Frequently  Always
How  often  treated
Dyspnoea  (namely  using  opioids)  12  (8.8)  29  (21.3)  44  (32.4)  41  (30.1)  10  (7.4)
Pain (namely  using  opioids)  20  (14.7)  20  (14.7)  62  (45.6)  23  (16.9)  11  (8.1)
Anxiety/depression  5  (3.7)  8  (5.9)  64  (47.1)  50  (36.8)  9  (6.6)
Data are presented as n (%).
Table  3  Frequency  and  topics  of  EoL  communication.
Never  Rarely  Occasionally  Frequently  Always
How  often  started  by
own  initiative  a  EoL
discussion
18  (13.2)  66  (48.5)  34  (25.0)  12  (8.8)  6  (4.4)
How often  discussed
The  evolution  of  the
disease
8  (5.9) 29  (21.3)  55  (40.4)  29  (21.3)  15  (11.0)
Life expectancy 33  (24.3) 62  (45.6) 28  (20.6)  7  (5.1)  6  (4.4)
How death  can
be/related  suffering
37  (27.2) 54  (39.7) 35  (25.7) 8  (5.9)  2  (1.5)
Patient’s spiritual  or
religious  beliefs
58  (42.6)  53  (39.0)  20  (14.7)  2  (1.5)  3  (2.2)
How often  suggested  patients  to  make  decisions  about
Invasive  mechanical
ventilation/intubation
39  (28.7)  54  (39.7)  27  (19.9)  10  (7.4)  6  (4.4)
Cardio-pulmonary
resuscitation
58 (42.6)  52  (38.2)  15  (11.0)  6  (4.4)  5  (3.7)
Place of  death  58  (42.6)  45  (33.3)  24  (17.6)  5  (3.7)  4  (2.9)
How often  suggested  the
elaboration  of  a
written  in  advance
directive  (living  will)
109  (80.1)  19  (14.0)  8  (5.9)  0  (0.0)  0  (0.0)
How often  referred
to  hospice  care
21  (15.4)  41  (30.1)  58  (42.6)  16  (11.8)  0  (0.0)
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nclude  religious  advisors.  About  half  (57.4%)  claimed  to
requently/always  include  relatives.
When  asked  how  often  they  excluded  the  patient  and
iscussed  EoL  only  with  caregivers,  most  (61.1%)  claimed
o  have  never/rarely  done  so.  Also,  63.3%  indicated  they
ever/rarely  made  EoL  decisions  just  with  health  providers.
ost  (64.0%)  claimed  to  have  never  changed  the  infor-
ation  given  to  patients/caregivers  in  order  to  inﬂuence
ecision  according  to  what  they  believe  is  best,  and  from
he  remaining,  most  said  they  only  did  this  rarely  (27.2%).
We  questioned  closely  as  to  how  difﬁcult  it  was  for
hysicians  to  hold  EoL  discussions  with  their  patients.
wenty-seven  answered  it  was  very  difﬁcult  (19.9%),  94  said
t  was  difﬁcult  (69.1%),  4  were  indifferent  (2.9%),  8  said  it
as  easy  (5.9%)  and  3  very  easy  (2.2%).  From  a  7-item  list,
e  asked  them  to  select  all  the  difﬁculties  usually  felt  in
oL  discussions.  Results  are  summarized  in  Table  5.
We  inquired  about  the  participants’  opinion  on  the  impor-
ance  of  discussing  EoL  with  advanced  COPD  patients.  Most
D
p
e
P76.5%)  rated  it  as  very  important,  31  (22.8%)  as  a  subject
f  some  importance,  with  only  one  participant  indicating
hat  it  was  of  little  importance.  Finally,  we  asked  if  par-
icipants  would  like  this  subject  to  be  further  discussed  in
cientiﬁc  meetings.  Almost  all  (98.5%)  agreed,  and  only  2
1.5%)  respondents  claimed  that  the  issue  is  being  sufﬁ-
iently  addressed  already.
There  were  no  statistical  signiﬁcant  differences  between
ears  of  practice,  type  of  institution  or  number  of  COPD
atients  treated  and  the  main  outcomes.
iscussionespite  the  increasing  interest  on  EoL  communication  and
alliative  care  in  end-stage  COPD,  this  is,  to  our  knowl-
dge,  the  ﬁrst  study  performed  in  Portugal  to  evaluate
ulmonologists′ perception  of  this  matter.
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Table  4  Interveners  in  EoL  communication.
Never  Rarely  Occasionally  Frequently  Always
How  often  included  other  interveners  in  EoL  discussion
Other  physicians  12  (8.8)  30  (21.1)  46  (33.8)  28  (20.6)  20  (14.7)
Nurses 33  (24.3)  42  (30.9)  35  (25.7)  21  (15.4)  5  (3.7)
Physiotherapists  56  (41.2)  30  (22.1)  36  (26.5)  12  (8.8)  2  (1.5)
Psychologists  62  (45.6)  30  (22.1)  36  (26.5)  7  (5.1)  1  (0.7)
Social workers  46  (33.8)  30  (22.1)  35  (25.7)  23  (16.9)  2  (1.5)
Religious advisor  83  (61.0)  41  (30.0)  10  (7.4)  2  (1.5)  0  (0.0)
Patient’s caregiver/family  2  (1.5)  16  (11.8)  40  (29.4)  45  (33.1)  33  (24.3)
How often  discussed  EoL  issues  only  with
caregivers/family,  and  excluded  the  patient
44  (32.4)  39  (28.7)  42  (30.9)  8  (5.9)  3  (2.2)
How often  changed  the  information  given  to
patients  or  their  caregivers/family  in  order
to inﬂuence  decision
87  (64.0)  37  (27.2)  10  (7.4)  1  (0.7)  1  (0.7)
How often  decided  on  EoL  only  with  health
professionals,  without  including  patients
or their  caregivers/family
33  (24.3)  53  (39.0)  33  (24.3)  16  (11.8)  1  (0.7)
Table  5  Obstacles  to  EoL  communication.
n  (%)
Feel  that  patients  are  not
prepared  to  discuss  these
issues
95  (69.9%)
Fear of  taking  away  patients’
hope
78  (57.4%)
Lack of  training  in  this  area  70  (51.5%)
Lack of  support/organization
in  the  work  institution
52  (38.2%)
Lack of  time  52  (38.2%)
Difﬁculty  in  predicting
progression  of  patient’s
disease
48  (35.3%)
Fear of  legal  repercussions  8  (5.9%)
None 5  (3.7%)
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Palliation  of  symptoms
Although  the  majority  of  physicians  reported  that  they
treated  symptoms  at  least  occasionally,  our  ﬁndings  sug-
gest  that  symptom  management  may  not  be  optimized.  Only
a  few  reported  using  opioids  routinely  in  the  treatment  of
dyspnoea  and  pain.  Since  opioids  are  the  only  drug  proven
to  be  effective  in  controlling  dyspnoea  in  these  patients,
these  results  are  clearly  unsatisfactory.7 Previous  studies
have  shown  evidence  of  poor  palliation  in  COPD.8--10 The
study  SUPPORT,  for  instance,  revealed  that  dyspnoea  occurs
more  often  in  these  patients  than  in  lung  cancer  patients.
In  the  same  study,  21%  of  patients  with  COPD  reported  suf-
fering  from  severe  pain.10 There  is  a  strong  possibility  that
analgesics  are  withheld  in  COPD  because  of  concerns  about
adverse  effects,  in  particular  respiratory  depression.  This
fear  is  unfounded,  since  there  is  no  evidence  to  date  that
the  doses  of  opioids  used  to  treat  breathlessness  causes
clinically  detectable  respiratory  depression  or  increases
mortality.7
It  has  been  suggested  that  anxiety/depression  affects
as  many  as  90%  of  advanced  COPD  patients,  but  previous
studies  have  reported  that  only  4--31%  were  receiving  phar-
macological  treatment.11,12 We  found  a  better  performance,
which  may  reveal  a  rising  awareness  of  the  beneﬁcial  effects
of  antidepressants  in  improving  mood  and  decreasing  dys-
pnoea  in  COPD  patients.13 Treating  depression  is  essential
since  it  may  modify  patient  decisions  concerning  EoL  care.14
Frequency  and  topics  of  end-of-life  communication
Another  important  outcome  of  this  study  was  to  realize
that  more  than  half  of  Portuguese  Pulmonologists  never  or
rarely  introduce  EoL  discussions  with  their  patients.  Previous
reports,  both  from  physician  and  patient  point  of  view,  have
also  shown  insufﬁcient  EoL  communication.15--17 One  of  the
topics  most  neglected  by  physicians  was  spiritual/religious
s
l
e
pData are presented as n (%); EoL = end-of-life.
eliefs,  although  there  is  evidence  that  the  majority  of
atients  want  to  discuss  these  issues.18
Although  advance  care  planning  seems  to  increase
atient  satisfaction  and  reduce  emotional  distress,  our
esults  show  that  physicians  have  used  little  initiative  in
ntroducing  it.18 The  lack  of  certainty  on  prognosis  strength-
ns  the  need  for  advance  directives  in  COPD,  but  the
vidence  is  they  are  rarely  used.  A  Survey  carried  out  in  the
uropean  Respiratory  Intermediate  care  units  showed  that
nly  30%  of  patients  admitted  to  having  had  a  formal  dis-
ussion  about  EoL  decisions  and/or  signed  a living  will.19 As
 result,  COPD  patients  are  more  likely  to  die  with  aggres-
ive,  technological  care  directed  at  preservation  of  life  and
ess  likely  to  receive  palliative  care,  despite  having  prefer-
nces  favouring  palliation.10 In  fact,  the  majority  of  COPD
atients  die  in  the  hospital,  mostly  in  intensive  care  units,
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lthough  at  least  half  of  clinically  stable  advanced  COPD
atients  would  prefer  to  die  in  their  home  environment.8,20
Hospice  care  in  end-stage  COPD  is  another  emerging
ssue.  The  recent  revised  version  of  GOLD  recommends
hat  clinicians  should  identify  COPD  patients  who  could
eneﬁt  from  palliative  care  services  and  help  ﬁnd  avail-
ble  resources  within  their  community.4 In  our  study,  about
alf  the  respondents  indicated  they  occasionally/frequently
efer  patients  to  hospice  care.  Nonetheless,  patients  dying
f  end-stage  COPD  are  in  general  less  likely  to  be  offered
ospice  services  compared  to  patients  with  lung  cancer.5
ncertainty  about  prognosis  as  well  as  doubts  as  to  whether
 traditional  hospice  model  is  suitable  for  patients  with
OPD,  may  explain  this  difference,  although  it  should  not
mpede  access  to  hospice  care.2
iming  and  interveners  in  end-of-life
ommunication
ecent  consensus  recommends  that  EoL  care  should  be  avail-
ble  early  during  the  course  of  the  disease,  from  when  the
atient  becomes  symptomatic.3 However,  contrary  to  this,
e  found  that  most  physicians  discuss  it  during/after  a  major
xacerbation.  Another  study  also  reported  that  discussions
ccur  mainly  in  advanced  stages  of  COPD,  that  is  when  dys-
noea  became  severe.21
There  are  more  growing  recommendations  on  the  use
f  interdisciplinary  health-care  teams  to  ensure  quality  EoL
are.2 Nonetheless,  we  found  poor  interdisciplinary  work  in
ur  study.  Results  were  similar  in  the  previously  mentioned
uropean  survey,  which  found  that  nurses  were  involved
n  55.9%,  but  only  in  a  small  minority  of  cases  were  opin-
ons  sought  from  other  professionals.  In  the  same  study,
atient’s  relatives  were  involved  in  discussion  in  only  about
alf  the  cases.19 We  in  turn,  found  a  better  performance  in
erms  of  engaging  the  family,  although  often  without  patient
articipation.  Interestingly,  our  participants  rarely  reported
odifying  the  information  provided  in  order  to  inﬂuence
ecisions,  a  phenomenon  that  was  reported  to  commonly
ccur  in  previous  studies.21,22
bstacles  in  end-of-life  communication
ost  participants  described  the  discussion  of  EoL  issues  as
eing  difﬁcult  or  very  difﬁcult,  which  makes  it  essential
o  understand  what  the  barriers  are  that  physicians  face,
specially  the  ones  that  can  be  modiﬁed.
As  in  a  previous  study,  the  feeling  that  patients  may  be
nprepared  to  discuss  these  matters  and  the  fear  of  tak-
ng  away  their  hope,  were  pointed  out  as  major  obstacles
o  communication.17 Patient  failure  to  understand  COPD
s  a  life-threatening  disease  and  their  will  to  concentrate
n  staying  alive  play  an  important  role  in  this  process.17
ultural  differences  possibly  have  an  inﬂuence  as  well.
n  a  European  survey  evaluating  public  preferences  for
elf-involvement  in  EoL  decision-making,  about  60%  of  the
ortuguese  participants  wanted  to  be  involved,  which  was
ess  than  the  European  mean  (74%).23 These  barriers  may
e  overcome  with  education  about  illness  progression  and
ncouragement  to  communicate.
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Other  obstacles  mentioned  by  our  respondents  have  to
o  with  organizational  aspects,  namely  lack  of  time,  lack
f  training  and  absence  of  protocols.  The  lack  of  formal
rotocols  to  initiate  EoL  was  also  pointed  out  by  Partridge
t  al.24 Additionally,  educational  practices  are  inadequate,
s  revealed  in  a  survey  performed  in  the  United  States.25
hese  aspects  represent  important  targets  for  intervention.
ach  institution  should  develop  policies  to  guide  health  staff
n  initiating  the  kind  of  EoL  care  that  is  feasible  in  their
ontext.2 Scientiﬁc  societies,  in  their  turn,  are  responsi-
le  for  ensuring  that  there  is  appropriate  education  on
oL  care  in  medical  schools  and  for  promoting  continuous
ducation  among  attendant  health-care  givers.  There  is
vidence  that  educational  programmes  and  even  smaller
nterventions  result  in  measurable  improvements  in  commu-
ication  skills.26--28 Moreover,  our  study  demonstrates  that
ulmonologists  are  interested  in  further  education  on  this
ubject.
Limited  resources  are  a  signiﬁcant  impediment  to  effec-
ive  EoL  care.  In  Portugal,  the  need  for  ﬁscal  consolidation
as  led  to  major  cuts  in  the  ﬁnancing  of  the  health  sector
n  recent  years.29 Despite  the  National  Program  for  Pallia-
ive  Care  which  was  created  in  2010,  numbers  show  that
esources  (regarding  number  of  hospice  care  beds  and  the
vailability  of  domiciliary  services)  are  still  far  behind  rec-
mmendations  by  the  European  Association  for  Palliative
are.29 These  restrictions  are  recognized  by  Portuguese  cit-
zens,  who  call  for  more  hospital  palliative  care  units  and
ore  palliative  care  access.30 Evidence-based  service  devel-
pment  using  existing  resources  may  be  part  of  the  solution.6
According  to  our  results,  the  particular  characteristics  of
 physician  do  not  seem  to  inﬂuence  their  ability  to  com-
unicate  on  EoL  issues,  which  suggests  that  the  barriers
dentiﬁed  are  transversal  to  different  practice  settings.
imitations  and  conclusions
he  present  study  has  a  number  of  potential  limitations.
The  Curtis  criterion  to  identify  candidates  for  EoL  dis-
ussion  may  be  subject  to  criticism.  It  is  a  presumptive
riterion,  since  it  has  not  been  proven  that  patients  who
re  included  die  sooner  or  have  more  symptoms.  Other  pro-
osed  criteria,  namely  the  CART  and  BODE  scores,  both  able
o  predict  mortality  in  patients  with  COPD,  would  be  equally
alid.31--33 Nonetheless,  we  believe  the  former  is  more  suit-
ble  for  the  purposes  of  this  type  of  questionnaire,  since  it
ncludes  a list  of  clinical  characteristics,  which  are  easier
o  answer  with  a  yes/no  response,  when  mentally  proﬁling
he  type  of  patients.  Whereas  CART  is  a  tree-algorithm  and
ODE  requires  a numeric  grading  of  each  variable,  both  of
hich  cases  would  make  this  process  more  difﬁcult.
Concerning  the  use  of  opioids  in  the  treatment  of  dysp-
oea,  we  retrospectively  realized  that  the  question  should
ave  been  put  in  a  more  objective  way.  Since  current
ecommendations  to  treat  dyspnoea  include  a  multimodal
pproach,  we  recognize  that  the  way  the  question  was
hrased  may  not  reveal  the  true  scale  of  opioids  use  for
his  purpose.
We  recognize  that  our  participation  rate  was  low.  How-
ver,  our  universe  included  an  unknown  number  of  retired
hysicians,  who  were  asked  not  to  answer  the  questionnaire,
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and  thus  underestimated  the  overall  response  rate.  Also,
the  choosing  to  use  a  web  platform  to  perform  the  survey,
may  have  inﬂuenced  the  response  rate  and  the  proﬁle  of  the
respondents.
Another  obvious  limitation  is  that  the  self-reported  infor-
mation  may  not  reﬂect  what  Pulmonologists  actually  do
in  practice.  Future  studies  should  ﬁnd  ways  of  quantifying
EoL  communication  more  objectively,  while  recognizing  that
research  in  this  area  is  hampered  by  important  ethical  and
methodological  challenges.34
In  conclusion,  our  study  demonstrated  that  our  palliative
care  and  EoL  communication  are  a  long  way  from  being  from
what  they  should  be.  Awareness,  training  in  this  ﬁeld  and  the
creation  of  formal  protocols  have  been  identiﬁed  as  major
areas  for  improvement,  and  should  be  encouraged.  Future
studies  should  focus  on  developing  and  testing  the  effective-
ness  of  practical  strategies  to  improve  EoL  communication
and  palliative  care  in  COPD.
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